1. Home
  2. ATRC vs PAHC Comparison

ATRC vs PAHC Comparison

Compare ATRC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • PAHC
  • Stock Information
  • Founded
  • ATRC 2000
  • PAHC 1946
  • Country
  • ATRC United States
  • PAHC United States
  • Employees
  • ATRC N/A
  • PAHC N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATRC Health Care
  • PAHC Health Care
  • Exchange
  • ATRC Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • ATRC 1.6B
  • PAHC 1.5B
  • IPO Year
  • ATRC 2005
  • PAHC 2014
  • Fundamental
  • Price
  • ATRC $33.13
  • PAHC $43.10
  • Analyst Decision
  • ATRC Strong Buy
  • PAHC Hold
  • Analyst Count
  • ATRC 9
  • PAHC 4
  • Target Price
  • ATRC $52.00
  • PAHC $31.25
  • AVG Volume (30 Days)
  • ATRC 618.7K
  • PAHC 330.5K
  • Earning Date
  • ATRC 10-29-2025
  • PAHC 11-05-2025
  • Dividend Yield
  • ATRC N/A
  • PAHC 1.11%
  • EPS Growth
  • ATRC N/A
  • PAHC 288.74
  • EPS
  • ATRC N/A
  • PAHC 1.67
  • Revenue
  • ATRC $518,304,999.00
  • PAHC $1,399,676,000.00
  • Revenue This Year
  • ATRC $16.90
  • PAHC $14.80
  • Revenue Next Year
  • ATRC $12.29
  • PAHC $3.16
  • P/E Ratio
  • ATRC N/A
  • PAHC $25.94
  • Revenue Growth
  • ATRC 15.80
  • PAHC 33.72
  • 52 Week Low
  • ATRC $28.29
  • PAHC $16.16
  • 52 Week High
  • ATRC $43.11
  • PAHC $46.42
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 45.22
  • PAHC 54.10
  • Support Level
  • ATRC $31.12
  • PAHC $43.71
  • Resistance Level
  • ATRC $33.98
  • PAHC $46.27
  • Average True Range (ATR)
  • ATRC 1.80
  • PAHC 2.16
  • MACD
  • ATRC -0.00
  • PAHC -0.07
  • Stochastic Oscillator
  • ATRC 39.16
  • PAHC 49.53

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: